FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

768652001: Equine antithymocyte immunoglobulin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3686369016 Equine antithymocyte immunoglobulin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3686370015 Equine antithymocyte immunoglobulin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Equine antithymocyte immunoglobulin Is a Equine derived substance (substance) true Inferred relationship Some
Equine antithymocyte immunoglobulin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some
Equine antithymocyte immunoglobulin Is a Antilymphocyte immunoglobulin (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely equine antithymocyte immunoglobulin 20 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Equine antithymocyte immunoglobulin Inferred relationship Some 1
Product containing precisely equine antithymocyte immunoglobulin 20 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Equine antithymocyte immunoglobulin Inferred relationship Some 1
Product containing only equine antithymocyte immunoglobulin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Equine antithymocyte immunoglobulin Inferred relationship Some 1
Equine antithymocyte immunoglobulin-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Equine antithymocyte immunoglobulin Inferred relationship Some 1
Equine antithymocyte immunoglobulin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Equine antithymocyte immunoglobulin Inferred relationship Some 1
Product containing only equine antithymocyte immunoglobulin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Equine antithymocyte immunoglobulin Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start